Express Scripts Drug Trend Quarterly Spotlight

Quarterly Spotlight - November 2012

2011 Drug Trend Report

Issue link: http://digital.turn-page.com/i/95262

Contents of this Issue

Navigation

Page 0 of 17

DRUG TREND Quarterly 01 QUARTERLY SPOTLIGHT Obesity Medications 04 in global sales expected by 2016. Over $3 billion 06 MORE ABOUT NEW OBESITY DRUGS READ MORE INFLATION BRAND DRUGS DRUG COSTS OUTPACE INFLATION 07 EXTRA PHARMACY LANDSCAPE PATTERNS DRUG STUDY FINDINGS POLICY DECISIONS READ MORE 02 TREND: YEAR-TO-DATE Q1 TREND QUARTERLY 7.2% TRADITIONAL SPECIALTY 3.4% 0.1% Q2 Q3 Q4 1 2 3 4 PUBLISHED BY: THE EXPRESS SCRIPTS RESEARCH & NEW SOLUTIONS LAB 03 SPEND: TRACKING THE TOP 3 TRADITIONAL Classes Top 3 YEAR-TO-DATE TREND -0.6% 22.6% 3.5% READ MORE NEW & NOTABLE DRUGS 05 SPECIALTY DRUGS DOMINATE NEW APPROVALS IN Q3 READ MORE PATENT EXPIRATIONS SPECIALTY Classes Top 3 59.2% YTD Spend Traditional 67.0% YTD Spend Specialty READ MORE SINGULAIR GOES OFF PATENT SALES DROP 90% READ MORE New 2012

Articles in this issue

view archives of Express Scripts Drug Trend Quarterly Spotlight - Quarterly Spotlight - November 2012